Comparative analysis of antibody induction and protection against influenza virus infection by DNA immunization with HA, HAe, and HA1 in mice
暂无分享,去创建一个
Jianjun Chen | Quanjiao Chen | Ze Chen | Yanfeng Yao | Huadong Wang | Chaochao Xiong | Qian Liu | Hanzhong Wang
[1] Hongjun Li,et al. Influenza A (H1N1) , 2015, Radiology of Infectious Diseases: Volume 1.
[2] D. W. Kim,et al. Sublingual administration of bacteria-expressed influenza virus hemagglutinin 1 (HA1) induces protection against infection with 2009 pandemic H1N1 influenza virus , 2013, Journal of Microbiology.
[3] G. Kobinger,et al. A Single Electroporation Delivery of a DNA Vaccine Containing the Hemagglutinin Gene of Asian H5N1 Avian Influenza Virus Generated a Protective Antibody Response in Chickens against a North American Virus Strain , 2013, Clinical and Vaccine Immunology.
[4] M. Steensels,et al. Potency of a Recombinant NDV-H5 Vaccine Against Various HPAI H5N1 Virus Challenges in SPF Chickens , 2012, Avian diseases.
[5] Jie Zhou,et al. A Recombinant Vaccine of H5N1 HA1 Fused with Foldon and Human IgG Fc Induced Complete Cross-Clade Protection against Divergent H5N1 Viruses , 2011, PloS one.
[6] S. Khurana,et al. Bacterial HA1 Vaccine against Pandemic H5N1 Influenza Virus: Evidence of Oligomerization, Hemagglutination, and Cross-Protective Immunity in Ferrets , 2010, Journal of Virology.
[7] A. García-Sastre,et al. Variations in the Hemagglutinin of the 2009 H1N1 Pandemic Virus: Potential for Strains with Altered Virulence Phenotype? , 2010, PLoS pathogens.
[8] S. Khurana,et al. Properly Folded Bacterially Expressed H1N1 Hemagglutinin Globular Head and Ectodomain Vaccines Protect Ferrets against H1N1 Pandemic Influenza Virus , 2010, PloS one.
[9] R. Webster,et al. Adaptation of Pandemic H1N1 Influenza Viruses in Mice , 2010, Journal of Virology.
[10] John Steel,et al. Influenza Virus Vaccine Based on the Conserved Hemagglutinin Stalk Domain , 2010, mBio.
[11] A. Osterhaus,et al. Introduction of Virulence Markers in PB2 of Pandemic Swine-Origin Influenza Virus Does Not Result in Enhanced Virulence or Transmission , 2010, Journal of Virology.
[12] Xiaofeng Liang,et al. Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial , 2010, The Lancet.
[13] K. Hoschler,et al. Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine. , 2009, The New England journal of medicine.
[14] X. Zhang,et al. A novel influenza A (H1N1) vaccine in various age groups. , 2009, The New England journal of medicine.
[15] C. Wichems,et al. Response to a monovalent 2009 influenza A (H1N1) vaccine. , 2009, The New England journal of medicine.
[16] Libo Dong,et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. , 2009, The New England journal of medicine.
[17] E. Ramsburg,et al. Intramuscular immunization with a vesicular stomatitis virus recombinant expressing the influenza hemagglutinin provides post-exposure protection against lethal influenza challenge. , 2009, Vaccine.
[18] L. Finelli,et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. , 2009, The New England journal of medicine.
[19] T. Kuiken,et al. Preclinical evaluation of a modified vaccinia virus Ankara (MVA)-based vaccine against influenza A/H5N1 viruses. , 2009, Vaccine.
[20] Guang Zeng,et al. Lack of Airborne Transmission during Outbreak of Pandemic (H1N1) 2009 among Tour Group Members, China, June 2009 , 2009, Emerging infectious diseases.
[21] Hideo Goto,et al. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses , 2009, Nature.
[22] Marion Koopmans,et al. Pathogenesis and Transmission of Swine-Origin 2009 A(H1N1) Influenza Virus in Ferrets , 2009, Science.
[23] Ron A M Fouchier,et al. Antigenic and Genetic Characteristics of Swine-Origin 2009 A(H1N1) Influenza Viruses Circulating in Humans , 2009, Science.
[24] Rahul Raman,et al. Transmission and Pathogenesis of Swine-Origin 2009 A(H1N1) Influenza Viruses in Ferrets and Mice , 2009, Science.
[25] Gavin J. D. Smith,et al. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic , 2009, Nature.
[26] E. Lyons,et al. Pandemic Potential of a Strain of Influenza A (H1N1): Early Findings , 2009, Science.
[27] J. Oxford,et al. DNA vaccination protects against an influenza challenge in a double-blind randomised placebo-controlled phase 1b clinical trial. , 2009, Vaccine.
[28] D. Tang,et al. Protection of chickens against avian influenza with nonreplicating adenovirus-vectored vaccine. , 2009, Poultry science.
[29] A. García-Sastre,et al. Human HA and polymerase subunit PB2 proteins confer transmission of an avian influenza virus through the air , 2009, Proceedings of the National Academy of Sciences.
[30] Jianjun Chen,et al. A single immunization with HA DNA vaccine by electroporation induces early protection against H5N1 avian influenza virus challenge in mice , 2009, BMC infectious diseases.
[31] John Steel,et al. Transmission of Influenza Virus in a Mammalian Host Is Increased by PB2 Amino Acids 627K or 627E/701N , 2009, PLoS pathogens.
[32] L. Balluz,et al. Effectiveness of 2008-09 trivalent influenza vaccine against 2009 pandemic influenza A (H1N1) - United States, May-June 2009. , 2009, MMWR. Morbidity and mortality weekly report.
[33] Robert Schechter,et al. Swine influenza A (H1N1) infection in two children--Southern California, March-April 2009. , 2009, MMWR. Morbidity and mortality weekly report.
[34] F. Fang,et al. Comparing the ability of a series of viral protein-expressing plasmid DNAs to protect against H5N1 influenza virus , 2009, Virus Genes.
[35] W. Hong,et al. Comparing the antibody responses against recombinant hemagglutinin proteins of avian influenza A (H5N1) virus expressed in insect cells and bacteria , 2008, Journal of medical virology.
[36] J. Kwang,et al. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant. , 2008, Virology.
[37] Yu Zhou,et al. Electroporation at Low Voltages Enables DNA Vaccine to Provide Protection against a Lethal H5N1 Avian Influenza Virus Challenge in Mice , 2008, Intervirology.
[38] Lucy A. Perrone,et al. A Single Mutation in the PB1-F2 of H5N1 (HK/97) and 1918 Influenza A Viruses Contributes to Increased Virulence , 2007, PLoS pathogens.
[39] D. Weiner,et al. Immunogenicity of novel consensus-based DNA vaccines against avian influenza. , 2007, Vaccine.
[40] Huálín Wáng,et al. Protection against avian influenza H9N2 virus challenge by immunization with hemagglutinin- or neuraminidase-expressing DNA in BALB/c mice. , 2006, Biochemical and biophysical research communications.
[41] Shuhan Sun,et al. Essential sequence of influenza neuraminidase DNA to provide protection against lethal viral infection. , 2006, DNA and cell biology.
[42] D. Suarez,et al. Development and Application of Reference Antisera against 15 Hemagglutinin Subtypes of Influenza Virus by DNA Vaccination of Chickens , 2006, Clinical and Vaccine Immunology.
[43] Jianjun Chen,et al. Protection against influenza virus infection in BALB/c mice immunized with a single dose of neuraminidase-expressing DNAs by electroporation. , 2005, Vaccine.
[44] K. Karaca,et al. Assessment of the efficacy of a single dose of a recombinant vaccine against West Nile virus in response to natural challenge with West Nile virus-infected mosquitoes in horses. , 2004, American journal of veterinary research.
[45] M. Itoh,et al. Analysis of epitope recognition of antibodies induced by DNA immunization against hemagglutinin protein of influenza A virus. , 2003, Vaccine.
[46] C. Secombes,et al. DNA vaccination against viral haemorrhagic septicaemia (VHS) in rainbow trout: size, dose, route of injection and duration of protection-early protection correlates with Mx expression. , 2003, Fish & shellfish immunology.
[47] J. Rousset,et al. Strategies to Improve Protection Against Low-Pathogenicity H7 Avian Influenza Virus Infection Using DNA Vaccines , 2003, Avian diseases.
[48] L. Babiuk,et al. Electroporation improves the efficacy of DNA vaccines in large animals. , 2002, Vaccine.
[49] A. Osterhaus,et al. DNA vaccination of ferrets with chimeric influenza A virus hemagglutinin (H3) genes. , 2002, Vaccine.
[50] G. Sachdeva,et al. Plasmid DNA immunization against Japanese encephalitis virus: immunogenicity of membrane-anchored and secretory envelope protein. , 2002, The Journal of infectious diseases.
[51] Yoshihiro Kawaoka,et al. Molecular Basis for High Virulence of Hong Kong H5N1 Influenza A Viruses , 2001, Science.
[52] S. Gurunathan,et al. DNA vaccines: immunology, application, and optimization*. , 2000, Annual review of immunology.
[53] H. Robinson,et al. DNA immunization: effect of secretion of DNA-expressed hemagglutinins on antibody responses. , 1999, Vaccine.
[54] L. Babiuk,et al. Altering the Cellular Location of an Antigen Expressed by a DNA-Based Vaccine Modulates the Immune Response , 1999, Journal of Virology.
[55] R. Webster,et al. DNA Vaccine Encoding Hemagglutinin Provides Protective Immunity against H5N1 Influenza Virus Infection in Mice , 1999, Journal of Virology.
[56] T. Iwasaki,et al. Comparison of the ability of viral protein-expressing plasmid DNAs to protect against influenza. , 1998, Vaccine.
[57] H. Aihara,et al. Gene transfer into muscle by electroporation in vivo. , 1998, Nature biotechnology.
[58] K. Mozdzanowska,et al. A pulmonary influenza virus infection in SCID mice can be cured by treatment with hemagglutinin-specific antibodies that display very low virus-neutralizing activity in vitro , 1997, Journal of virology.
[59] L. Reed,et al. A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS , 1938 .